• Policy
• MFDS approves the orphan drug 'Pluvicto' for prostate cancer
• by Lee, Hye-Kyung May 31, 2024 05:51am

• Policy
• Korea-US gov't pledge to strengthen biohealth cooperation
• by Lee, Jeong-Hwan May 31, 2024 05:51am

• Policy
• Research on reforming post-management of pharmaceuticals
• by Lee, Tak-Sun May 30, 2024 05:50am

• Policy
• MSD discontinues supply of Zostavax in Korea
• by Lee, Hye-Kyung May 30, 2024 05:50am

• Policy
• Antengene starts Xpovio's reimb pricing negotiations in KOR
• by Lee, Tak-Sun May 29, 2024 05:45am

• Policy
• Only 15 of the 61 Trajenta generics will be released in KOR
• by Lee, Tak-Sun May 29, 2024 05:45am

• Policy
• New dementia drug Leqembi receives approval
• by Lee, Hye-Kyung May 27, 2024 05:48am

• Policy
• Tepmetko reapplies for reimb in Korea for the third time
• by Lee, Tak-Sun May 27, 2024 05:48am

• Policy
• Companies can apply for multiple clinical protocols at once
• by Lee, Hye-Kyung May 24, 2024 05:48am

• Policy
• New drug Tibsovo is approved in Korea
• by Lee, Hye-Kyung May 23, 2024 05:49am